Bildkälla: Stockfoto

Scandion Oncology: Sights set on the immuno-oncology arena - Redeye

Redeye comments on Scandion announcing the conclusion of its immuno-oncology collaboration with Alligator Biosciences. With positive results in hand, we believe Scandion is now ready to explore combinations of SCO-101 and immuno-oncology drugs more broadly.

Redeye comments on Scandion announcing the conclusion of its immuno-oncology collaboration with Alligator Biosciences. With positive results in hand, we believe Scandion is now ready to explore combinations of SCO-101 and immuno-oncology drugs more broadly.
Börsvärldens nyhetsbrev
ANNONSER